Definition of autoimmunity
Autoimmunity is an immune response directed against the body’s own antigens, caused by activation of self-reactive T lymphocytes, B lymphocytes, or both.
Normally, the immune system is self-tolerant: it recognizes foreign antigens but does not attack self. Autoimmunity results when this tolerance fails.
Autoimmunity is not always autoimmune disease. Autoantibodies or self-reactive lymphocytes may occur without tissue injury. An autoimmune disease develops when the autoimmune response causes clinically significant inflammation, cellular dysfunction, or tissue destruction.
Mechanisms of autoimmunity
Autoimmunity usually arises through the interaction of:
- Genetic susceptibility
- Failure of self-tolerance
- Environmental trigger, commonly infection, tissue injury, drugs, or altered self-antigens
- Persistent immune-mediated tissue damage
1. Failure of self-tolerance
Self-reactive lymphocytes are normally controlled by central and peripheral tolerance mechanisms.
A. Defective central tolerance
Central tolerance occurs during lymphocyte development:
- T cells mature in the thymus. Strongly self-reactive T cells are normally deleted by apoptosis, and some become regulatory T cells (Tregs).
- B cells mature in bone marrow. Self-reactive immature B cells may undergo:
- Receptor editing: change their antigen receptor specificity
- Deletion: apoptosis of strongly self-reactive cells
- Anergy: functional inactivation
Failure of these processes allows autoreactive T or B cells to leave the thymus or bone marrow and enter the circulation.
Cellular and Molecular Immunology, Chapter 15, p. 3414-3429.
B. Defective peripheral tolerance
Self-reactive cells that escape central tolerance are normally kept inactive in peripheral tissues by:
- Anergy: antigen recognition without adequate co-stimulation makes lymphocytes unresponsive.
- Deletion: repeated stimulation may cause apoptosis, including Fas-mediated death.
- Suppression by regulatory T cells: Tregs suppress autoreactive lymphocytes through inhibitory cytokines and cell-contact mechanisms.
- Immune ignorance: certain self-antigens are normally inaccessible, present in too low an amount, or not presented with sufficient co-stimulation.
Breakdown of any of these peripheral control mechanisms can activate autoreactive lymphocytes.
Janeway’s Immunobiology 10e, p. 2419.
2. Genetic susceptibility
Some individuals inherit genes that increase the likelihood of loss of tolerance.
- The strongest associations are often with particular HLA alleles, because HLA molecules determine which peptides are presented to T cells.
- Certain HLA types may present self-peptides more effectively, allowing activation of autoreactive T cells.
- Genes affecting lymphocyte activation, apoptosis, cytokine signaling, antigen clearance, and Treg function can also increase risk.
Examples include associations of particular HLA types with type 1 diabetes mellitus, celiac disease, ankylosing spondylitis, systemic lupus erythematosus, and other autoimmune disorders.
Goodman & Gilman’s The Pharmacological Basis of Therapeutics, p. 248-254.
3. Release of sequestered or hidden self-antigens
Some self-antigens are normally hidden from the immune system in immune-privileged sites, such as:
- Eye
- Testis
- Central nervous system
Trauma, infection, inflammation, or surgery may expose these previously sequestered antigens. Since tolerance may not have developed against them, they can provoke an immune response.
Example: After trauma to one eye, immune responses to ocular antigens may damage both eyes, termed sympathetic ophthalmia.
4. Altered self-antigens or neoantigen formation
A normal self-protein can be altered by:
- Drugs or drug metabolites
- Chemicals
- Infection
- Radiation or tissue injury
- Post-translational changes, such as citrullination
The altered self-protein may appear foreign and stimulate T cells and antibodies. The immune reaction can then cross-react with normal tissue.
Example: Some drugs bind host proteins and act as haptens, making the protein immunogenic.
5. Molecular mimicry
Molecular mimicry occurs when a microbial antigen resembles a host antigen structurally or antigenically.
An immune response against the pathogen then cross-reacts with similar self-antigens, leading to tissue injury.
Examples:
- Rheumatic fever: antibodies and T cells generated against group A streptococcal antigens cross-react with cardiac tissue.
- Guillain-Barré syndrome: antibodies formed after Campylobacter jejuni infection may cross-react with peripheral nerve gangliosides.
Molecular mimicry is most likely to produce disease in a genetically susceptible person and in the setting of inflammation.
Tietz Textbook of Laboratory Medicine, p. 2963; Goodman & Gilman’s The Pharmacological Basis of Therapeutics, p. 248-254.
6. Bystander activation
During infection or tissue damage, inflammation produces cytokines, upregulates co-stimulatory molecules on antigen-presenting cells, and causes tissue-cell injury.
This inflammatory setting may activate nearby autoreactive T cells non-specifically, even if their specific self-antigen was not the original trigger. This is called bystander activation.
Infections may therefore break peripheral tolerance by creating an environment rich in co-stimulation and inflammatory cytokines.
7. Epitope spreading
Initially, an autoimmune response may target one self-epitope. Tissue destruction then releases additional self-antigens, producing immune responses against new epitopes.
This expansion of the autoimmune response is termed epitope spreading.
It establishes a vicious cycle:
- Initial autoimmune response causes inflammation and tissue injury.
- Damaged cells release more self-antigens.
- New autoreactive T and B cells become activated.
- The disease becomes broader, more persistent, and more severe.
Cellular and Molecular Immunology, p. 1680-1686; Harrison’s Principles of Internal Medicine 22E, p. 908-911.
8. Defective clearance of apoptotic cells and immune complexes
Normally, apoptotic cells and cellular debris are removed rapidly, preventing exposure of intracellular antigens.
Defective clearance can lead to prolonged exposure of nuclear and cytoplasmic antigens. These antigens may be taken up by antigen-presenting cells and stimulate autoreactive B and T cells.
This mechanism is particularly relevant in systemic lupus erythematosus, where antibodies may develop against nuclear antigens such as DNA, histones, and ribonucleoproteins.
How autoimmune injury occurs
Once tolerance is lost, tissue damage may result through three main immune mechanisms:
| Mechanism | How injury occurs | Example |
|---|
| Autoantibody-mediated injury | Antibodies bind cell or tissue antigens, activate complement, opsonize cells, or alter receptor function | Autoimmune hemolytic anemia, myasthenia gravis, Graves disease |
| Immune-complex injury | Antigen-antibody complexes deposit in tissues and trigger inflammation | Systemic lupus erythematosus |
| T-cell-mediated injury | Cytotoxic T cells destroy target cells, or helper T cells activate macrophages and inflammation | Type 1 diabetes mellitus, multiple sclerosis |
Summary flowchart
Genetic predisposition
- failure of central/peripheral tolerance
- environmental trigger such as infection, trauma, drug, or tissue injury
↓
Activation of autoreactive T cells and B cells
↓
Autoantibody formation, immune-complex deposition, or T-cell-mediated inflammation
↓
Tissue damage and release of additional self-antigens
↓
Epitope spreading and chronic autoimmune disease